kolaviron has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeniyi, PA; Agedah, AE; Awogbindin, IO; Farombi, EO; Ogbuewu, E; Olorunkalu, PD; Oyetunde, BF | 1 |
| Asogwa, NT; Moses, BO; Olajide, OJ; Oyegbola, CB | 1 |
2 other study(ies) available for kolaviron and Nerve Degeneration
| Article | Year |
|---|---|
Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson's disease.
Topics: Animals; Corpus Striatum; Dopaminergic Neurons; Flavonoids; Gastrointestinal Microbiome; Male; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders; Plant Extracts; Rats; Rotenone; Stereotaxic Techniques; Substantia Nigra | 2020 |
Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.
Topics: Aluminum Chloride; Aluminum Compounds; Alzheimer Disease; Animals; Antioxidants; Cell Death; Cerebral Cortex; Chlorides; Flavonoids; Hippocampus; Nerve Degeneration; Neuroglia; Neurons; Neuroprotective Agents; Oxidative Stress; Plant Extracts; Rats; Sodium Azide; Superoxide Dismutase | 2017 |